Login
$TXMD
$1.83 +$0.02 (1.08%) After hours

Ownership

13F as of Q2 2026 · 11.6M shares outstanding

Who owns TXMD?

By type of holder
Institutions 31.7% Insiders 24.5% Everyone else 43.8%
Concentration Top 10 holders own 35.9%
Rubric Capital Management LP 10.3% · Bernick Brian 6.8%
Institutional ownership
31.7%
-2.3 pts vs last qtr
Institutional holders
44
-5 vs last qtr
Net shares bought
−264.1K
by institutions in Q2 2026
New / sold out
4 / 9
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • ADAR1 Capital Management, LLC +133.2K
  • Citadel Advisors LLC +17.8K

Sign up to see all 5.

Biggest sellers in Q2 2026
  • Squadron Capital Management LLC SOLD OUT −420.4K
  • Susquehanna International Group, LLP SOLD OUT −21.2K

Sign up to see all 5.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for TherapeuticsMD, Inc. in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2016–FY2025
+195.0%
+12.77% a year
Each share's claim on the business
−66.1%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $85.6M
over 10 fiscal years
Diluted shares, split-adjusted
10.1K5.8M11.7M2016: 3.9M shares'162017: 4.1M shares'172018: 4.5M shares'182019: 4.9M shares'192020: 5.5M shares'202021: 8.0M shares'212022: 9.4M shares'222023: 10.4K shares'232024: 11.5M shares'242025: 11.6M shares'25
Buybacks Stock-based comp
$0$9.1M$18.1M2016 buybacks: $02016 stock comp: $17.4M'162017 buybacks: $02017 stock comp: $6.9M'172018 buybacks: $02018 stock comp: $8.7M'182019 buybacks: $02019 stock comp: $10.7M'192020 buybacks: $02020 stock comp: $10.7M'202021 buybacks: $02021 stock comp: $18.1M'212022 buybacks: $02022 stock comp: $11.6M'222023 buybacks: $02023 stock comp: $1.3M'232024 buybacks: $02024 stock comp: $264.0K'242025 buybacks: $02025 stock comp: $75.0K'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years0% 3–5 years83% 1–3 years13% Under 1 year4%
Quarterly turnover
8.4%
of institutional shares changed hands
Top 10 managers, median time held
3.5 years

Super Investors

Investment managers reporting TXMD on Form 13F
RC
Rubric Capital Management LP
Shares
1.2M
% of company
10.30%
Change vs last qtr
Unchanged
Held since
2022
CC
Clearline Capital LP
Shares
635.2K
% of company
5.49%
Change vs last qtr
Unchanged
Held since
2022

28 more super investors behind a free account

See every manager holding TherapeuticsMD, Inc., how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting TXMD on Form N-PORT; together they hold 4.2% of the company
VT
Position value
$540K
% of company
2.11%
% of the fund
0.00%
As of
June 30, 2026
VE
Position value
$242K
% of company
0.95%
% of the fund
0.00%
As of
June 30, 2026

13 more funds behind a free account

See every fund holding TherapeuticsMD, Inc. and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
BB
Bernick Brian
Insider
Shares
783.4K
% of company
6.77%
Change vs last qtr
—
Held since
—
TT
Thompson Tommy G
Insider
Shares
114.5K
% of company
0.99%
Change vs last qtr
—
Held since
—

3 more holders behind a free account

See every insider and 5%+ holder of TherapeuticsMD, Inc..

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support